Thromboprophylaxis with low molecular weight heparin (Dalteparin) in pregnancy

Thrombosis Research

Volumn 96, Issue 4, 1999, Pages 275-282

  Pettilä, Ville ^a   Kaaja, Risto ^a   Leinonen, Pekka ^a   Ekblad, Ulla ^b   Kataja, Matti ^c   Ikkala, Eero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Dalteparin; LMW heparin; Pregnancy; Randomised, Osteoporosis; Thromboprophylaxis

Indexed keywords

DALTEPARIN; HEPARIN;

ADULT; ALLERGIC REACTION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; DALTEPARIN; DEMOGRAPHY; FEMALE; FRACTURES, BONE; HEMORRHAGE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LUMBOSACRAL REGION; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOSIS; TREATMENT OUTCOME;

EID: 0032724913     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00110-3     Document Type: Article

References (26)

1. Sachs B.P., Brown D.A.J., Driscoll S.G., Schulman E., Acker D., Ransil B.J., Jewett J.F. Maternal mortality in Massachusetts. Trends and prevention. N Engl J Med. 316:1987;667-672.
2. Nelson-Piercy C., Letsky E.A., de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis. Experience of sixty-nine pregnancies in sixty-one women of high risk Am J Obstet Gynecol. 176:1997;1062-1068.
3. Högberg U. Maternal deaths in Sweden 1971-1980. Acta Obstet Gynecol Scand. 65:1986;161-167.
4. Sipes S.L., Weiner C.P. Venous thromboembolic disease in pregnancy. Semin Perinatol. 14:1990;103-118.
5. Letsky E.A., de Swiet M. Thromboembolism in pregnancy and its management. Br J Haematol. 57:1984;543-552.
6. Rutherford S., Montoro M., McGehee W., Strong T. Thromboembolic disease associated with pregnancy. An 11-year review (abstract) Am J Obstet Gynecol. 164(Suppl):1991;286.
7. De Swiet M., Floyd E., Letsky E. Low risk of recurrent thromboembolism in pregnancy (letter). Br J Hosp Med. 38:1987;264.
8. Howell R., Fidler J., Letsky E. The risk of antenatal subcutaneous heparin prophylaxis. A controlled trial Br J Obstet Gynaecol. 90:1983;1124-1128.
9. Tengborn L., Bergqvist D., Mätzsch T., Bergqvist A., Hedner U. Recurrent thromboembolism in pregnancy and puerperium. Is there need for thromboprophylaxis? Am J Obstet Gynecol. 160:1989;90-94.
10. Badaracco M.A., Vessey M.P. Recurrence of venous thromboembolic disease and the use of oral contraceptives. BMJ. 1:1974;215-217.
11. Hall J.A.G., Paul R.M., Wilson K.M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 68:1980;122-140.
12. Melissari E., Parker C.J., Wilson N.V., Monte G., Kanthou C., Pemberton K.D., Nicolaides K.H., Barrett J.J., Kakkar V.V. Use of low molecular weight heparin in pregnancy. Thromb Haemost. 68:1992;652-656.
13. Forestier F., Sóle Y., Aiach M., Gélas M.A., Daffos F. Absence of transplacental passage of Fragmin during the second and third trimester of pregnancy. Thromb Haemost. 67:1992;180-181.
14. Greer I.A., de Swiet M. Thrombosis prophylaxis in obstetrics and gynaecology. Br J Obstet Gynaecol. 100:1993;37-40.
15. Ginsberg J.S., Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 108(Suppl):1995;305S-311S.
16. Toglia M.R., Weg J.G. Venous thromboembolism during pregnancy. N Engl J Med. 335:1996;108-114.
17. Hunt B.J., Doughty H.-A., Majumdar G., Copplestone A., Buchanan N., Hughes G., Khamashta M. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Hemost. 77:1997;39-43.
18. Dulitzki M., Pauzner R., Langevitz P., Pras M., Many A., Schiff E. Low-molecular-weight heparin during pregnancy and delivery. Preliminary experience with 41 pregnancies Obstet Gynecol. 87:1996;380-383.
19. Nelson-Piercy C., Letsky E.A., de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis. Experience of sixty-nine pregnancies in sixty-one women at high risk Am J Obstet Gynecol. 176:1997;1062-1068.
20. Dahlman T.C. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 168:1993;1265-1270.
21. Bratt G., Åberg W., Johansson M., Törnebohm E., Granqvist S., Lockner D. Two daily subcutaneus injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis. Br Med J. 64:1990;506-510.
22. Leizorovics A., Haugh M.C., Chapuis F.-R., Samana M.M., Boissel J.-P. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ. 305:1992;913-920.
23. Low molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med. 337:1997;657-662.
24. Blömback M., Bremme K., Hellgren M., Lindberg H. A pharmacokinetic study of dalteparin (Fragmin) during the late pregnancy. Blood Coagulation Fibrinolysis. 9:1998;343-350.
25. Monreal M., Olive A., Lafoz E., del Rio L. Heparins, coumarin and bone mineral density. Lancet. 338:1991;706.
26. Dahlman T. Heparin and osteoporosis. Studies on longterm thromboprophylaxis in pregnancy. Academic dissertation. Stockholm, Sweden: Karolinska Hospital; 1992.